Mercedes-Benz USA, LLC
Summary
NHTSA campaign 22V937: Mercedes-Benz USA, LLC recalled for a safety defect. A loss of rear wheel control and drive power can increase the risk of a crash. In addition, differential oil that leaks
Details
Source
nhtsa
External ID
22V937
Action Date
2022-12-19
Status
Ongoing
Category
vehicle
Product Description
Mercedes-Benz USA, LLC (MBUSA) is recalling certain 2022 AMG G63 4x4-squared vehicles. The rear axle differential housing may crack, leaking oil onto the road. In addition, the rear axle differential housing may break, resulting in a loss of rear wheel control and drive power.
Company
Context & Analysis
Mercedes-Benz USA, LLC has 149 FDA actions in our database.
Frequently Asked Questions
How often does Mercedes-Benz USA, LLC have FDA actions?
Mercedes-Benz USA, LLC has 149 FDA actions in our database, including 0 recalls and 0 device clearances.
Where can I find the official FDA record?
The official record is available on FDA.gov. Use the link above to view the complete official filing. You can also use the openFDA API to query this record programmatically.
Want to know the moment something like this happens?
Get alerts for vehicle